Stablecoin Development Corp
SDEVNYSE
$1.25
↑ +0.8%Jul 17 close · end-of-day
Price
1Y↓ -41.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$207.1M
Enterprise Value
$188.7M
P/E
—
P/S
—
P/B
1.5
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$86.0M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-62.0%
ROIC
11.2%
Debt / Equity
—
Net Cash
$18.4M
Return 1Y
-41.8%
Company profile
NovaBay Pharmaceuticals, Inc. develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials from skin around the eye, such as the eyelid. The company also provides dermatological solutions for acne, skin care, and skin care products under the DERMAdoctor brand.
- CEO
- Justin M. Hall
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 30
- Headquarters
- California
- Website
- novabay.com
Management & directors
- Kazley Michael JohnChief Executive Officer
- R01 Fund LpChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
SDEV Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$2.5M—
Diluted EPS$3.33↓ -53.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $10.2M | $14.4M | $10.5M | $9.8M | — |
| Gross profit | $6.0M | $6.5M | $7.8M | $6.1M | $6.5M | — |
| Operating income | -$6.4M | -$8.9M | -$14.4M | -$4.1M | -$7.4M | -$8.4M |
| Net income | -$11.0M | -$5.8M | -$10.6M | -$9.6M | -$7.2M | -$630.8M |
| Diluted EPS | -$0.31 | — | — | — | — | — |
| Operating cash flow | -$4.7M | -$9.2M | -$6.7M | -$4.1M | -$7.5M | -$8.4M |
| Free cash flow | -$4.7M | -$9.2M | -$6.8M | -$4.2M | -$7.5M | — |
| Gross margin | 60.0% | 63.8% | 54.0% | 58.2% | 66.3% | — |
| Operating margin | -64.7% | -86.8% | -100.1% | -39.2% | -75.4% | — |
| Net margin | -111.1% | -57.1% | -73.6% | -92.2% | -73.8% | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4M | $0.00 | $4.8M | $0.00 | — | $521,000.00 | — | $2.5M |
| Gross profit | $1.6M | $0.00 | $3.1M | — | — | $42,000.00 | — | — |
| Operating income | -$1.6M | -$1.7M | -$1.8M | -$3.3M | -$1.9M | -$1.3M | -$2.0M | $22.3M |
| Net income | -$1.6M | -$1.2M | -$1.2M | $7.7M | -$1.9M | -$1.3M | -$635.2M | $552.4M |
| Diluted EPS | -$1.37 | -$1.92 | — | $7.08 | -$0.33 | -$0.22 | — | $3.33 |
| Operating cash flow | -$1.4M | -$2.4M | -$1.7M | -$1.3M | -$3.0M | -$1.8M | -$2.3M | -$1.8M |
| Free cash flow | -$1.4M | -$2.4M | -$1.7M | -$1.3M | -$3.0M | -$1.8M | — | — |
| Gross margin | 66.3% | — | 65.2% | — | — | 8.1% | — | — |
| Operating margin | -67.4% | — | -37.2% | — | — | -241.1% | — | 905.0% |
| Net margin | -66.0% | — | -25.5% | — | — | -248.2% | — | 22428.1% |
Company news
Apr 15, 2026
Mar 23, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-15 | Framework Ventures IV L.P. | X | 11,332,020 | $0.00 | $27,196.85 | filing |
| 2026-06-15 | Kazley Michael John· Chief Executive Officer | X | 11,332,020 | $0.00 | $27,196.85 | filing |
| 2026-06-15 | R01 Fund LP· Chief Executive Officer | X | 11,332,020 | $0.00 | $27,196.85 | filing |
| 2026-06-15 | Kazley Michael John· Chief Executive Officer | Sale | 24,720 | $1.09 | $26,944.80 | filing |
| 2026-06-15 | Framework Ventures IV L.P. | Sale | 24,720 | $1.09 | $26,944.80 | filing |
| 2026-06-15 | R01 Fund LP· Chief Executive Officer | Sale | 24,720 | $1.09 | $26,944.80 | filing |
| 2025-10-21 | Kazley Michael John· Chief Executive Officer | C | 56,806,080 | $0.00 | $0.00 | filing |
| 2025-10-21 | Kazley Michael John· Chief Executive Officer | C | 11,361,216 | $0.00 | $0.00 | filing |
| 2025-10-21 | Framework Ventures IV L.P. | C | 11,361,216 | $0.00 | $0.00 | filing |
| 2025-10-21 | R01 Fund LP· Chief Executive Officer | C | 11,361,216 | $0.00 | $0.00 | filing |
| 2025-10-21 | Framework Ventures IV L.P. | C | 56,806,080 | $0.00 | $0.00 | filing |
| 2025-10-21 | R01 Fund LP· Chief Executive Officer | C | 56,806,080 | $0.00 | $0.00 | filing |
| 2025-10-21 | Lazar David E. | Award | 6,388,000 | — | — | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.